Simultaneous suppression of multiple oncogenes is an attractive strategy to treat cancers. Herein we present a series of long double-stranded multiplex siRNAs (multi-siRNAs) which is suitable for dual genes silencing through a sequence specific RNA interference process without inducing significant immune responses. A gap feature structurally designed in either of the nucleotide strands of the multi-siRNAs was proved to be essential towards silencing target genes and avoiding immune responses. Furthermore, the silencing effect of multi-siRNAs against survivin and bcl-2 genes was shown to be effective and resulted in up-regulation of caspase 3 related apoptosis and, in turn, inhibition of bladder cancer cell proliferation. Our observation suggested that the rationally designed multi-siRNAs would have great potential for therapeutic siRNA design.
cytoplasmic RNase III enzyme, will cleave it into 21 to 23 bp dsRNA with 2 nt 3' overhangs, which is termed small interfering RNA (siRNA) (Zamore et al., 2000) .
RNA-induced silencing complex (RISC) loads the antisense strand of siRNA then recognizes and cleaves the target mRNAs with complementary sequences, and thus shows effective gene silencing (Elbashir et al., 2001 ).
Because of efficient and specific silencing of target gene expression, siRNA has recently been experimentally used to treat cancers. However, inhibition of a single oncogenic gene is insufficient to kill tumor cells, because oncogenesis is correlated with multiple genes involved in multiple pathways (Menendez et al., 2004) . Therefore, developing multi-target siRNAs could be an advantageous strategy, by which multiple genes expression can be inhibited simultaneously and thus may lead to more effective
anticancer therapies than what single-target siRNA could achieve. In addition to multi-cassette shRNAs (Watanabe et al., 2006) and long hairpin shRNAs (Sano et al., 2008) , studies on synthetic multi-target siRNAs have also been reported. Hossbach M. et al. (Hossbach et al., 2006) reported a dual-targeting siRNA composed of two fully target-complementary guide strands, with the strands partially complementary to each other. An algorithm was further developed to predict dual-targeting siRNAs of complete complementary strands which acted as active guide strands separately targeting different mRNAs (Tiemann, et al., 2010) . However, both methods suffered from limitation of the algorithm, and the designed siRNA may not be the most efficient sequence. A recent study reported that long synthetic siRNA duplexes (38bp) simultaneously knocked-down expression of two genes without triggering an F o r P e e r R e v i e w interferon response (Chang et al., 2009 ). This, however, contradicted the results from a previous study, in that double-stranded RNAs longer than 30bp could not execute specific gene silencing due to induction of interferon response (Elbashir et al., 2001 ).
In the present study, we designed a new, long, double-stranded multiplex siRNA (multi-siRNA) structures targeting survivin and bcl-2 genes with a gap in either the sense strand or the antisense strand. Further experiments proved that the multi-siRNAs were capable of silencing both target genes efficiently in an Ago-2 dependent manner without interferon responses, and thus, significantly suppressed proliferation in T24 cells.
Materials and Methods

Single targeting siRNAs sequence selection and multiplex-siRNAs design
Single-target siRNAs targeting human survivin mRNA (si-S1~si-S3) were selected from a full-site siRNA library of survivin constructed by Biomics Biotechnologies Co.
Ltd (Nantong, China). Individual siRNAs targeting human bcl-2 (si-B1, si-B2) were designed using Thermo siDESIGN Center and Invitrogen BLOCK-iT RNAi Designer online tools. After screening the most efficient single-target siRNA sequences, multi-siRNAs were designed accordingly, with the sequences listed in Table 1 . To enhance stability of the multi-siRNA, 2'-OMe modification was incorporated in both of the strands on every second nucleotide (Czauderna et al., 2003) . siRNA targeting luciferase gene (si-GL3) was used as a negative control. All the siRNAs were chemically synthesized by Biomics Biotechnologies (Nantong, China).
Cell culture and siRNA transfection F o r P e e r R e v i e w T24 cells were conserved in Biomics and maintained in RPMI-1640 medium (GIBCO, USA) supplemented with 10% FBS, 100 units/mL penicillin, and 100 µg/mL streptomycin at 37℃ in 5% CO 2 humidified atmosphere. Cells grown to a confluence of 30%-40% were transfected with siRNAs by lipofectamine 2000 (Invitrogen, USA) according to manufacturer's guidelines. 10nM concentration of siRNAs was used in all experiments unless stated otherwise.
Quantitative real-time reverse transcription PCR (q-RT-PCR)
A RISO™ RNA isolation reagent (Biomics Biotech, Nantong, China) was used to extract total RNA from cell lysates. The cDNA was produced by reverse transcription and expression levels of human survivin and bcl-2 mRNA were determined by a quantitative RT-PCR method using EzOmics TM one-step qPCR kit (Biomics Biotech, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   ago2 reverse: 5'-TCCCAGACGCCCTGGACAGG-3' GAPDH forward: 5'-GAAGGTGAAGGTCGGAGTC-3'
GAPDH reverse: 5'-GAAGATGGTGATGGGATTTC-3'
Samples were tested in triplicate. GAPDH expression was used as an internal control.
Western blotting
Cells were seeded in 6-well plates respectively. When the confluence of cells reached 50%, transfection was conducted with siRNA and lipofectamine 2000 as described above. After further incubation for 48h, the cells were lysed using mammalian cell total protein lysis buffer (Sangon Biotech, Shanghai, China). Fifty micrograms of total proteins were separated in 12% SDS acrylamide gels and electroblotted onto an immobilon PVDF membrane (Millipore, Billerica, MA, USA). The membranes were blocked for 2h in PBST containing 5% skim milk powder, and incubated overnight at 4 ℃ with a 1/100 dilution of mouse monoclonal primary antibody to human Survivin (Santa Cruz Biotech, USA), or a 1/200 dilution of mouse monoclonal antibody to human Bcl-2(Santa Cruz Biotech, USA) and human GAPDH (Santa Cruz Biotech, USA), respectively. The membranes were then washed in PBST and incubated with a 1/1000 dilution of goat anti-mouse HRP-conjugated secondary antibody (Jackson ImmunoResearch, USA) at room temperature for 2h. After incubation with ECL chemiluminescence reagent (Beyotime Institute of Biotechnology, Nantong, China), the membranes were exposed to a film (Kodak, Japan). 
Interferon (IFN) responses assay
Cell proliferation assay
Cells were seeded in 96-well plates at 2000 cells per well 24h prior to transfection, and then transfection was conducted as described above. At scheduled time points, cell proliferation capacity was measured in triplicate using cell counting kit according to the manufacturer's specifications (Beyotime Institute of Biotechnology, Nantong, China).
Apoptosis analysis
To measure early and late apoptotic cells, cells were stained with FITC-conjugated Annexin V and propidium iodide (PI) using Annexin V-FITC Apoptosis Detection Kit (KeyGen Biotech, China) and analyzed by FACScan flow cytometry (BD Biosciences, Heidelberg, Germany) 48h after siRNA transfection.
Caspase 3 activity assay
Total proteins were extracted from transfected cells using mammalian cell total protein lysis buffer (Sangon Biotech, Shanghai, China) as described above. Protein concentration of the whole cell extract was measured by Bradford assay. Activity of caspase 3 was determined using a caspase 3 activity kit (Beyotime Institute of Biotechnology, Nantong, China) according to the manufacturer's instructions. One 
Statistical analysis
Data were expressed as means ± S.D.. Difference between any two groups was determined by One Way ANOVA analysis. Difference is considered to be significant statistically when P-value is <0.05 .
Results
Selection of efficient siRNA targeting human survivin or bcl-2 respectively
siRNAs targeting human survivin gene (si-S1~si-S3) or human bcl-2 gene (si-B1 and si-B2) were transfected into T24 cells in a final concentration of 10nM, respectively.
After transfection for forty-eight hours, survivin or bcl-2 mRNA levels were measured by q-RT-PCR. The results showed that si-S3 led to a significant decrease in survivin mRNA expression, at 79% relative to that in the negative control, and si-B1 was the most effective siRNA targeting bcl-2 gene with 84% gene knock-down efficiency ( Fig.   1 ). The results were further confirmed by Western blotting analysis ( Fig. 2) , in which si-S3 and si-B1 significantly suppressed expression of survivin and bcl-2 protein, respectively.
Effect of multi-siRNAs on bcl-2 and survivin gene expression.
We designed three types of structures based on double stranded multi-siRNAs from the sequences of si-S3 and si-B1, and named Sub-1, Sub-2 and Sub-3, respectively, as mRNA and protein levels of survivin and bcl-2 genes were determined by q-RT-PCR and Western blotting assays, respectively. In the cells treated with Sub-1, a down-regulation of survivin mRNA to about 66% and bcl-2 mRNA to 83% was observed. In comparison, Sub-2 induced a down-regulation of survivin and bcl-2 mRNA to 71% and 81%, respectively (Fig.3) . Western blotting assays further demonstrated that Sub-1 and Sub-2 inhibited the expression of Survivin and Bcl-2 proteins more efficient than Sub-3 (Fig. 4) . In light of these results, further studies focused on the effective multi-siRNAs (Sub-1 and Sub-2).
No significant interferon responses induced by multi-siRNAs
It was known that dsRNA longer than 30bp ( 
Gene silencing by multi-siRNAs in an Ago2-dependent manner
To study whether multi-siRNAs silence genes via the same Ago2-dependent pathway (Fig. 6) .
The cells were then further transfected with multi-siRNAs and single target siRNAs, respectively. After culture for additional 24h, the expression of survivin and bcl-2 gene were measured. As shown in Fig.7 , gene knock-down by individual siRNAs (si-S3 and si-B1) or multi-siRNAs (Sub-1 and Sub-2) was effectively blocked by pre-treatment with Ago2 gene-specific siRNA. The result revealed that multi-siRNAs trigger gene silencing in an Ago2-dependent pathway.
Inhibition of cell proliferation by multi-siRNAs
T24 cells were transfected with Sub-1, Sub-2, si-S3, si-B1 or a combination of si-S-3
and si-B-3, respectively. Cells transfected with si-GL3 siRNA were used as a negative control. At scheduled time points, cells were counted by a CCK-8 method. Relative viability rates of T24 cells were normalized to si-GL3 treated cells (=100%) and shown in Fig. 8 . At 48h, 72h, 96h and 120h after transfection, inhibition of cell proliferation was observed in all the targeting siRNA groups compared to the negative control group. At 48h after treatment with 10 or 20nM of si-S3, the relative proliferation rates of T24 cells were 80.36%±5.61% and 57.82%±11.85%, respectively (P<0.05, compared to si-GL3 control). In si-B1, Sub-1 and Sub-2 transfected groups, the same trend was also observed, in which the relative proliferation rates decreased with increased amount of siRNA used. The results indicated that the effects on growth inhibition were siRNAs dose-dependent.
Furthermore, we noticed that the inhibitory effects of siRNAs were also 
Enhancement of cell apoptosis by multi-siRNAs
Since survivin and bcl-2 are known as anti-apoptosis genes, blocking of survivin or bcl-2 gene is expected to cause an increase of apoptosis (Montazeri et al, 2011; Kunze et al., 2008) . Rates of apoptosis were measured in T24 cells after treatment with siRNAs by flow cytometry assays. As shown in Fig. 9 , individual si-S3 or si-B1 treatment produced an augmentation of apoptosis to 20.96% and 18.45%, respectively, compared to the negative control which displayed an apoptosis rate of 6.35%. An increase in induced apoptosis by multi-siRNAs was also observed. Sub-1 infection led to a 18.63% in apoptosis, whereas Sub-2 infection resulted apoptosis up to 23.63%.
Up-regulation of caspase 3 activity by multi-siRNAs
It is known that apoptosis involves a cascade of proteolytic reactions affected chiefly by the caspase family, and caspase-3 is thought to be the major executor of apoptosis (Porter and Janicke, 1999) . Therefore, we attempted to analyze the levels of caspase-3 activity resulted from siRNAs treatment. As shown in Fig.10 , increases by 1.57 fold and 1.77 fold in apoptotic caspase 3 activity were seen for si-S3 and si-B1 Furthermore, much greater increases of active caspase 3 were observed in Sub-1 and Sub-2 treatment groups (3.70-fold and 3.64-fold higher than si-GL3 control, respectively, P<0.05).
Discussion
In the present study, we designed two new multi-siRNA structures composed of an intact long strand (at least 30 nucleotides in length) and two complementary shorter strands. There is a gap between the two shorter strands, which results in the segmentation of the complementary strand. We then synthesized a variety of multi-siRNAs targeting human survivin and human bcl-2 genes, and proved that Sub-1 and Sub-2 with a gap in either of the strands could effectively silence two target genes simultaneously with the high potency as compared to corresponding single target siRNAs. However, gene knock-down efficacy of double-long stranded siRNA (Sub-3) was poor ( Fig. 3 and Fig. 4) , although there was no difference in the nucleotide sequences between Sub-3 and Sub-1 (Sub-2). The results indicated that the gap in either of antisense or sense strand is essential to the silencing activities of multi-siRNAs, and the knock-down potency of multi-siRNAs depends on the specific structures to a certain extent. It is well known that long dsRNA in cells will be digested by a dsRNA-specific endonuclease, Dicer, into siRNA duplexes as functional effectors to cleave target mRNAs. Therefore, the gap between the two complementary strands may provide recognizable sites and/or facilitate the process of Dicer, thus the resultant two siRNAs would then silence their targets, respectively. However, the A preliminary study on the mechanism of specific gene silencing effects induced by multi-siRNAs was further studied. It is widely accepted that siRNA-directed RNA interference is mediated by Ago2. As a core component of RISC, Ago2 protein functions as a slicer to cleave target mRNA and offers a binding site for siRNA in RISC assembly (Liu et al., 2004; Rand et al., 2005) . Therefore, we studied the function of Ago2 on multi-siRNAs induced gene silencing. As shown in Fig. 7 , gene silencing effects of multi-siRNAs were blocked by down regulating expression of Ago2 gene. We concluded that the silencing effect induced by multi-siRNAs also requires Ago2 as a catalysis and is likely to be Ago2-dependent, and therefore it follows the same pathway as that utilized by conventional siRNAs.
A previous study reported that dsRNA longer than 30bp could not execute specific were used in this study as sensitive biomarkers to evaluate immune responses resulted from dsRNA. The levels of OAS1 and IFIT1 mRNAs from multi-siRNAs treated T24 cells were measured against those from conventional siRNAs being used as a control.
The results indicated that multi-siRNAs with a gap in either of the strands didn't evoke significant interferon responses, nor did single target siRNAs. However, long OAS1 mRNA levels, although Sub-3 is also selectively modified by 2' OMe nucleotides. Therefore, we included that the lack of immune response from multi-siRNAs was due to the specific structures to some extent. These findings demonstrated that in vitro gene silencing activities of multi-siRNAs against respective target genes were derived from sequence-specific RNA interference rather than an IFN response.
It is presently accepted that anticancer agents are effective to lead to death of tumor cells only when they induce apoptosis. However, apoptosis is frequently dysregulated in tumor cells, by which cancer cells become resistant to anticancer drug treatments.
Over-expression of anti-apoptotic genes, such as bcl-2 and survivin, has been shown to play a critical role in apoptosis deficiency (Kasibhatla and Tseng, 2003; Varfolomeev and Vucic, 2011) . Therefore, we designed multi-siRNAs (Sub-1 and Sub-2) targeting survivin and bcl-2 genes simultaneously to mitigate the apoptosis deficiency of bladder cancer T24 cells. In the study, we revealed that RNAi suppression of survivin or bcl-2 genes individually resulted in a small decrease in cell growth and a modest increase in spontaneous cell apoptosis. In contrast, when suppression of survivin and bcl-2 was achieved at the same time by Sub-1 or Sub-2, the proliferation of T24 cells was dramatically inhibited and the apoptosis was enhanced by a significant activation of caspase-3. We could conclude based on the results that Sub-1 and Sub-2 demonstrated to be more effective on inhibition of cancer (2003) Characterization of the 2′-5′-oligoadenylate synthetase ubiquitin-like family. Nucleic.
Acids. Res. 31, 3166-3173.
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